JP2015502740A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502740A5 JP2015502740A5 JP2014537335A JP2014537335A JP2015502740A5 JP 2015502740 A5 JP2015502740 A5 JP 2015502740A5 JP 2014537335 A JP2014537335 A JP 2014537335A JP 2014537335 A JP2014537335 A JP 2014537335A JP 2015502740 A5 JP2015502740 A5 JP 2015502740A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- ibd
- antibody
- value
- panca2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 68
- 208000011231 Crohn disease Diseases 0.000 claims 27
- 238000000034 method Methods 0.000 claims 26
- XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 claims 19
- 239000003550 marker Substances 0.000 claims 14
- 238000002965 ELISA Methods 0.000 claims 12
- 238000007637 random forest analysis Methods 0.000 claims 9
- 238000007619 statistical method Methods 0.000 claims 9
- 206010009900 Colitis ulcerative Diseases 0.000 claims 8
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 8
- 238000003066 decision tree Methods 0.000 claims 5
- 230000002068 genetic effect Effects 0.000 claims 5
- 210000002966 serum Anatomy 0.000 claims 5
- 102100031758 Extracellular matrix protein 1 Human genes 0.000 claims 4
- 101000866526 Homo sapiens Extracellular matrix protein 1 Proteins 0.000 claims 4
- 108010017324 STAT3 Transcription Factor Proteins 0.000 claims 4
- 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 230000000405 serological effect Effects 0.000 claims 4
- 102100040355 Autophagy-related protein 16-1 Human genes 0.000 claims 3
- 102100027890 Homeobox protein Nkx-2.3 Human genes 0.000 claims 3
- 101000964092 Homo sapiens Autophagy-related protein 16-1 Proteins 0.000 claims 3
- 101000632181 Homo sapiens Homeobox protein Nkx-2.3 Proteins 0.000 claims 3
- 238000003556 assay Methods 0.000 claims 3
- 230000035945 sensitivity Effects 0.000 claims 3
- 108010040721 Flagellin Proteins 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 108091006374 cAMP receptor proteins Proteins 0.000 claims 1
- 238000003205 genotyping method Methods 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 230000002055 immunohistochemical effect Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550293P | 2011-10-21 | 2011-10-21 | |
| US61/550,293 | 2011-10-21 | ||
| US201161553853P | 2011-10-31 | 2011-10-31 | |
| US61/553,853 | 2011-10-31 | ||
| US201161567096P | 2011-12-05 | 2011-12-05 | |
| US61/567,096 | 2011-12-05 | ||
| US201161570271P | 2011-12-13 | 2011-12-13 | |
| US61/570,271 | 2011-12-13 | ||
| PCT/US2012/061202 WO2013059732A1 (en) | 2011-10-21 | 2012-10-19 | Methods for improving inflammatory bowel disease diagnosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502740A JP2015502740A (ja) | 2015-01-29 |
| JP2015502740A5 true JP2015502740A5 (cg-RX-API-DMAC7.html) | 2015-12-10 |
Family
ID=48141435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537335A Pending JP2015502740A (ja) | 2011-10-21 | 2012-10-19 | 炎症性腸疾患の診断を改善するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8715943B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2769321B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2015502740A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012325798B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2852954A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL232167A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX352274B (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201401536QA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013059732A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| AU2010236568B2 (en) | 2009-04-14 | 2015-08-27 | Société des Produits Nestlé S.A. | Inflammatory bowel disease prognostics |
| WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
| MX362132B (es) | 2011-05-10 | 2019-01-07 | Nestec Sa | Metodos para perfilado de actividad de enfermedad para manejo de terapia personalizado. |
| WO2014160883A1 (en) | 2013-03-27 | 2014-10-02 | Cedars-Sinai Medical Center | Treating fibrosis and inflammation by inhibiting tl1a |
| WO2014182689A1 (en) * | 2013-05-06 | 2014-11-13 | Yacyshyn Bruce R | Method of using biomarkers in predicting inflammatory bowel disease |
| EP3498867B1 (en) | 2013-05-17 | 2021-09-29 | Cedars-Sinai Medical Center | Variants of tnfsf15 and dcr3 associated with crohn's disease |
| CN105392780A (zh) * | 2013-05-24 | 2016-03-09 | 雀巢产品技术援助有限公司 | 用于预测肠易激综合征诊断的途径特异性测定 |
| US10316083B2 (en) | 2013-07-19 | 2019-06-11 | Cedars-Sinai Medical Center | Signature of TL1A (TNFSF15) signaling pathway |
| US11568982B1 (en) | 2014-02-17 | 2023-01-31 | Health at Scale Corporation | System to improve the logistics of clinical care by selectively matching patients to providers |
| WO2016007544A1 (en) * | 2014-07-11 | 2016-01-14 | Matatu, Inc. | Use of a gut microbiome as a predictor of animal growth or health |
| CN104131102B (zh) * | 2014-08-07 | 2016-06-15 | 马飞 | 一种判断nsclc患者对吉非替尼治疗反应性的试剂盒 |
| US11809501B2 (en) * | 2014-08-28 | 2023-11-07 | Ebay Inc. | Systems, apparatuses, and methods for providing a ranking based recommendation |
| HK1244881A1 (zh) * | 2014-12-02 | 2018-08-17 | Société des Produits Nestlé S.A. | 建立维多珠单坑给药方案以治疗患有易激惹肠病的患者的方法 |
| AU2016209478B2 (en) | 2015-01-20 | 2019-03-07 | Nantomics, Llc | Systems and methods for response prediction to chemotherapy in high grade bladder cancer |
| AU2016226162B2 (en) * | 2015-03-03 | 2017-11-23 | Nantomics, Llc | Ensemble-based research recommendation systems and methods |
| US11037070B2 (en) * | 2015-04-29 | 2021-06-15 | Siemens Healthcare Gmbh | Diagnostic test planning using machine learning techniques |
| EP3411120B8 (en) * | 2016-02-02 | 2023-06-21 | Maximus Diagnostic Technologies LLC | Assessment of intestinal barrier function to improve treatment of inflammatory bowel disease |
| US10295527B2 (en) | 2016-03-14 | 2019-05-21 | Bruce Yacyshyn | Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis |
| US11946927B2 (en) | 2016-03-14 | 2024-04-02 | Musidora Biotechnology Llc | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
| KR20240095481A (ko) | 2016-03-17 | 2024-06-25 | 세다르스-신나이 메디칼 센터 | Rnaset2를 통한 염증성 장 질환의 진단 방법 |
| EP3458466B1 (en) * | 2016-05-20 | 2024-08-07 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease based on genes |
| JP7111322B2 (ja) * | 2016-12-02 | 2022-08-02 | 国立大学法人 東京大学 | 線維化関連分子に対する抗体およびその医療応用 |
| WO2018112209A1 (en) * | 2016-12-14 | 2018-06-21 | Warren Tracy | System and methods for developing and using a microbiome-based action component for patient health |
| US11978543B2 (en) | 2016-12-14 | 2024-05-07 | Astarte Medical Partners Inc. | System and methods for developing and using a microbiome-based action component |
| US10409734B1 (en) * | 2017-03-27 | 2019-09-10 | Symantec Corporation | Systems and methods for controlling auxiliary device access to computing devices based on device functionality descriptors |
| CN108784666B (zh) * | 2017-05-04 | 2023-01-13 | 深圳市生码医疗科技有限公司 | 连续监测心血管的精准医疗系统及数据处理方法 |
| AU2018277256A1 (en) | 2017-05-31 | 2020-01-30 | Prometheus Biosciences, Inc. | Methods for assessing mucosal healing in Crohn's disease patients |
| WO2019195146A1 (en) * | 2018-04-03 | 2019-10-10 | Boston Scientific Scimed, Inc. | Systems and methods for diagnosing and/or monitoring disease |
| EP3818544B1 (en) * | 2018-07-05 | 2025-05-28 | Boston Scientific Scimed, Inc. | Devices, systems, and methods for determining inflammation and/or fibrosis |
| WO2020041287A1 (en) * | 2018-08-21 | 2020-02-27 | Yacyshyn Bruce R | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
| WO2020113116A1 (en) * | 2018-11-29 | 2020-06-04 | Cedars-Sinai Medical Center | Methods of stratifying and treating a sub-population of inflammatory bowel disease patients |
| WO2020117795A1 (en) * | 2018-12-04 | 2020-06-11 | Prometheus Biosciences, Inc. | Assessment and monitoring of mucosal healing in children and adults with crohn's disease |
| EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
| WO2020219549A1 (en) * | 2019-04-23 | 2020-10-29 | Cedars-Sinai Medical Center | Methods and systems for assessing inflammatory disease with deep learning |
| JP2022532381A (ja) * | 2019-05-16 | 2022-07-14 | プロサイセデクス インコーポレイティド | Ｖｃａｍ－１及びカルプロテクチンのための分析検出方法 |
| CN110373457B (zh) * | 2019-06-20 | 2023-03-14 | 镇江市第一人民医院 | 一种用于溃疡性结肠炎诊断的mRNA标志物及其应用 |
| CN111417124A (zh) * | 2019-06-28 | 2020-07-14 | 西南交通大学 | 在认知无线网络环境下频谱感知的方法 |
| US12224041B2 (en) * | 2020-03-06 | 2025-02-11 | Laboratory Corporation Of America Holdings | Assay for hemoglobin a (HBA) detection and genotyping |
| US11610679B1 (en) * | 2020-04-20 | 2023-03-21 | Health at Scale Corporation | Prediction and prevention of medical events using machine-learning algorithms |
| CA3180628A1 (en) * | 2020-06-03 | 2021-12-09 | Rebecca GONSKY | Treatments for a sub-population of inflammatory bowel disease patients |
| US12094582B1 (en) | 2020-08-11 | 2024-09-17 | Health at Scale Corporation | Intelligent healthcare data fabric system |
| US12080428B1 (en) | 2020-09-10 | 2024-09-03 | Health at Scale Corporation | Machine intelligence-based prioritization of non-emergent procedures and visits |
| US20230363695A1 (en) * | 2020-09-16 | 2023-11-16 | Northwestern University | Classification of functional lumen imaging probe data |
| CA3194324A1 (en) * | 2020-10-05 | 2022-04-14 | Dermot MCGOVERN | Methods and systems for stratifying inflammatory bowel disease patients |
| JP2024501620A (ja) * | 2020-12-04 | 2024-01-15 | アイカーン スクール オブ メディシン アット マウント サイナイ | 生物学的障害の動的免疫組織化学プロファイリングのためのシステム及び方法 |
| US20240044916A1 (en) * | 2020-12-11 | 2024-02-08 | Icahn School Of Medicine At Mount Sinai | Methods of monitoring inflammatory bowel diseases |
| JP7655721B2 (ja) * | 2020-12-18 | 2025-04-02 | 花王株式会社 | 疲労マーカー及びそれを用いた疲労の検出方法 |
| JP7655720B2 (ja) * | 2020-12-18 | 2025-04-02 | 花王株式会社 | ストレスマーカー及びそれを用いた慢性ストレスレベルの検出方法 |
| GEAP202416351A (en) | 2021-02-17 | 2024-02-12 | Dr Falk Pharma Gmbh | Anti-cd30l antibodies and uses thereof |
| US20240404053A1 (en) * | 2021-09-22 | 2024-12-05 | Janssen Research & Development, Llc | Automatic Estimation of Ulcerative Colitis Severity from Endoscopy Videos USING ORDINAL MULTI-INSTANCE LEARNING |
| CA3243342A1 (en) * | 2022-01-28 | 2023-08-03 | University Of Southern California | IDENTIFICATION OF NON-DISEALED PATIENTS USING DISEASE-ASSOCIATED ASSAY AND ANALYSIS IN LIQUID BIOPSY |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4277250A (en) | 1979-12-10 | 1981-07-07 | Baylor College Of Medicine | Methods for detecting and quantifying occult blood |
| JPH0684970B2 (ja) | 1987-03-31 | 1994-10-26 | 株式会社京都医科学研究所 | 糞便中の潜血検出方法 |
| US5081040A (en) | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
| US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
| JPH0736013B2 (ja) | 1991-04-27 | 1995-04-19 | 一男 田畑 | 潜血検出用試薬 |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| DK0615129T3 (da) | 1993-03-10 | 2000-08-07 | Cedars Sinai Medical Center | Fremgangsmåder til selektiv påvisning af perinukleært anti-neutrophilt cytoplasmatisk antistof fra ulcerativ colitis eller |
| US5830675A (en) | 1993-03-10 | 1998-11-03 | Cedars-Sinai Medical Center | Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis |
| AU696455C (en) | 1994-03-23 | 2006-03-02 | Case Western Reserve University | Compacted nucleic acids and their delivery to cells |
| US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
| US5844107A (en) | 1994-03-23 | 1998-12-01 | Case Western Reserve University | Compacted nucleic acids and their delivery to cells |
| US5972901A (en) | 1994-03-23 | 1999-10-26 | Case Western Reserve University | Serpin enzyme complex receptor--mediated gene transfer |
| US6033864A (en) | 1996-04-12 | 2000-03-07 | The Regents Of The University Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
| US6074835A (en) | 1996-04-12 | 2000-06-13 | Regents Of The Univ. Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1 |
| US5916748A (en) | 1996-04-12 | 1999-06-29 | Cedars-Sinai Medical Center | Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis |
| US5932429A (en) | 1996-04-12 | 1999-08-03 | Cedars-Sinai Medical Center | Methods of diagnosing clinical subtypes of crohn's disease |
| US5750479A (en) | 1997-02-14 | 1998-05-12 | Bandon Corp. | Enclosed fluid system conditioner and process therefor |
| AU4145597A (en) | 1997-02-20 | 1998-09-09 | Cedars-Sinai Medical Center | Ulcerative colitis panca secretory vesicle antigen and methods of using sa me |
| US6218129B1 (en) | 1998-05-15 | 2001-04-17 | Prometheus Laboratories, Inc. | Inflammatory bowel disease first step assay system |
| US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
| US6309643B1 (en) | 1999-04-30 | 2001-10-30 | The Regents Of The University Of California | IBD-associated microbial antigens and methods of using same |
| WO2000071096A2 (en) | 1999-05-24 | 2000-11-30 | Introgen Therapeutics, Inc. | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| FR2802536B1 (fr) | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
| FR2806739B1 (fr) | 2000-03-27 | 2005-02-18 | Fond Jean Dausset Ceph | Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| US7138237B1 (en) | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
| US20020042388A1 (en) | 2001-05-01 | 2002-04-11 | Cooper Mark J. | Lyophilizable and enhanced compacted nucleic acids |
| US6821739B2 (en) | 2000-10-13 | 2004-11-23 | The Regents Of The University Of California | Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens |
| US20020150626A1 (en) | 2000-10-16 | 2002-10-17 | Kohane Daniel S. | Lipid-protein-sugar particles for delivery of nucleic acids |
| US7060442B2 (en) | 2000-10-30 | 2006-06-13 | Regents Of The University Of Michigan | Modulators on Nod2 signaling |
| ES2486340T3 (es) | 2000-10-30 | 2014-08-18 | The Regents Of The University Of Michigan | Ácidos nucleicos y proteínas Nod2 |
| DK1330525T3 (da) | 2000-10-30 | 2013-03-04 | Univ Michigan | NOD2-nukleinsyrer og proteiner |
| US20050164929A1 (en) | 2000-11-06 | 2005-07-28 | Lupine Logic, Inc. | Methods of preventing and treating inflammatory bowel disease |
| EP1340078B1 (en) | 2000-11-14 | 2009-05-27 | Techlab, Inc. | Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrin as a marker |
| US20030203865A1 (en) | 2001-04-30 | 2003-10-30 | Pierrot Harvie | Lipid-comprising drug delivery complexes and methods for their production |
| ES2405790T3 (es) | 2001-12-17 | 2013-06-03 | Corixa Corporation | Composiciones y métodos para la terapia y el diagnóstico de enfermedad inflamatoria del intestino |
| US20030204507A1 (en) | 2002-04-25 | 2003-10-30 | Li Jonathan Qiang | Classification of rare events with high reliability |
| US20040053263A1 (en) | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
| ATE395596T1 (de) | 2002-10-25 | 2008-05-15 | Techlab Inc | Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon |
| AU2003298703A1 (en) | 2002-11-22 | 2004-06-18 | Emory University | Diagnostic tests and methods for diagnosing inflammatory bowel disease |
| US7662569B2 (en) | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
| JPWO2004095021A1 (ja) | 2003-04-23 | 2006-07-13 | エーザイ株式会社 | 疾患予後モデルの作成方法、このモデルを用いた疾患予後予測方法、このモデルによる予後予測装置、ならびにそのプログラム・記憶媒体 |
| US20040242972A1 (en) | 2003-05-28 | 2004-12-02 | General Electric Company | Method, system and computer product for prognosis of a medical disorder |
| US20050060295A1 (en) | 2003-09-12 | 2005-03-17 | Sensory Networks, Inc. | Statistical classification of high-speed network data through content inspection |
| CA2549971A1 (en) | 2003-11-03 | 2005-05-12 | Duke University | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| CA2554836A1 (en) | 2004-02-05 | 2005-08-25 | Medtronic, Inc. | Methods and apparatus for identifying patients at risk for life threatening arrhythmias |
| US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US7759079B2 (en) | 2004-05-13 | 2010-07-20 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US20060019410A1 (en) | 2004-07-21 | 2006-01-26 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| CA2589746A1 (en) | 2004-12-08 | 2006-06-15 | Cedars-Sinai Medical Center | Methods for diagnosis and treatment of crohn's disease |
| US7873479B2 (en) * | 2005-12-01 | 2011-01-18 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20100015156A1 (en) | 2007-03-06 | 2010-01-21 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease in children |
| US8153443B2 (en) | 2007-05-10 | 2012-04-10 | Cedars-Sinai Medical Center | Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease |
| EP2267827A4 (en) | 2008-03-27 | 2012-04-18 | Jx Nippon Oil & Energy Corp | FUEL CELL SYSTEM AND METHOD OF LOAD OPERATION OF THIS SYSTEM |
| US20100129838A1 (en) * | 2008-11-11 | 2010-05-27 | Prometheus Laboratories Inc. | Methods for prediction of inflammatory bowel disease (ibd) using serologic markers |
| AU2010236568B2 (en) * | 2009-04-14 | 2015-08-27 | Société des Produits Nestlé S.A. | Inflammatory bowel disease prognostics |
| CA2766157A1 (en) * | 2009-06-25 | 2010-12-29 | Hua Gong | Methods for diagnosing irritable bowel syndrome |
| EP2504457A4 (en) * | 2009-11-25 | 2013-08-14 | Nestec Sa | NOVEL GENOMIC BIOMARKERS USED IN THE DIAGNOSIS OF IRRITABLE COLON SYNDROME |
| WO2011153501A2 (en) | 2010-06-04 | 2011-12-08 | Prometheus Laboratories Inc. | Methods for improving inflammatory bowel disease diagnosis |
-
2012
- 2012-10-19 JP JP2014537335A patent/JP2015502740A/ja active Pending
- 2012-10-19 MX MX2014004712A patent/MX352274B/es active IP Right Grant
- 2012-10-19 SG SG11201401536QA patent/SG11201401536QA/en unknown
- 2012-10-19 CA CA2852954A patent/CA2852954A1/en not_active Abandoned
- 2012-10-19 WO PCT/US2012/061202 patent/WO2013059732A1/en not_active Ceased
- 2012-10-19 EP EP12841790.4A patent/EP2769321B1/en active Active
- 2012-10-19 AU AU2012325798A patent/AU2012325798B2/en not_active Ceased
-
2013
- 2013-03-15 US US13/840,779 patent/US8715943B2/en active Active
-
2014
- 2014-03-28 US US14/229,715 patent/US20150072879A1/en not_active Abandoned
- 2014-04-22 IL IL232167A patent/IL232167A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502740A5 (cg-RX-API-DMAC7.html) | ||
| Butler et al. | Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions | |
| Gerich et al. | Towards personalized care in IBD | |
| NZ595471A (en) | Inflammatory bowel disease prognostics | |
| Kumar et al. | Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure | |
| Norman et al. | Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis | |
| Ayers et al. | Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay | |
| JP2016520199A5 (cg-RX-API-DMAC7.html) | ||
| JP2015510122A5 (cg-RX-API-DMAC7.html) | ||
| Verfaillie et al. | Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease | |
| JP2015533213A5 (cg-RX-API-DMAC7.html) | ||
| CN110643703B (zh) | bTMB生物标记、测定方法和用途 | |
| RU2017115663A (ru) | Способы и системы для отличия синдрома раздраженного кишечника от воспалительного заболевания кишечника и глютеновой болезни | |
| Kao et al. | Genome‐wide identification of blood DNA methylation patterns associated with early‐onset hepatocellular carcinoma development in hepatitis B carriers | |
| Wu et al. | Report on the 14th international society of blood transfusion platelet immunology workshop | |
| Kiladjian et al. | Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies | |
| JP2015231362A5 (cg-RX-API-DMAC7.html) | ||
| Lao et al. | Hematological factors associated with immunity, inflammation, and metabolism in patients with systemic lupus erythematosus: Data from a Zhuang cohort in Southwest China | |
| Zupančič et al. | Multi-locus genetic risk score predicts risk for Crohn’s disease in Slovenian population | |
| Zhou et al. | The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China | |
| Yoshimura et al. | Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease | |
| Gusev | Germline mechanisms of immunotherapy toxicities in the era of genome‐wide association studies | |
| WO2009049257A3 (en) | Predictive models and methods for diagnosing and assessing coronary artery disease | |
| Karpman et al. | Chronic obstructive pulmonary disease among lung cancer-free smokers: the importance of healthy controls | |
| JP2014239679A5 (cg-RX-API-DMAC7.html) |